ALTOBELLI, DEBORA
 Distribuzione geografica
Continente #
AS - Asia 88
NA - Nord America 64
EU - Europa 39
SA - Sud America 27
Totale 218
Nazione #
US - Stati Uniti d'America 60
SG - Singapore 38
BR - Brasile 20
CN - Cina 14
IT - Italia 13
HK - Hong Kong 9
VN - Vietnam 9
KR - Corea 8
DE - Germania 7
RU - Federazione Russa 7
AR - Argentina 4
AT - Austria 3
EC - Ecuador 3
FI - Finlandia 3
IN - India 3
CA - Canada 2
GB - Regno Unito 2
JP - Giappone 2
MX - Messico 2
BH - Bahrain 1
ID - Indonesia 1
IE - Irlanda 1
KW - Kuwait 1
LB - Libano 1
NL - Olanda 1
PL - Polonia 1
SE - Svezia 1
UZ - Uzbekistan 1
Totale 218
Città #
Singapore 20
Ashburn 9
Hong Kong 9
Seoul 8
Bologna 5
Columbus 5
Ho Chi Minh City 5
Boardman 4
New York 4
Piscataway 4
Chennai 3
Los Angeles 3
Nuremberg 3
Padova 3
Vienna 3
Dallas 2
Hanoi 2
Hefei 2
Mexico City 2
Montecassiano 2
Munich 2
Porto Alegre 2
Santa Clara 2
The Dalles 2
Tokyo 2
Turku 2
As Sālimīyah 1
Bauru 1
Beijing 1
Belo Horizonte 1
Boston 1
Bình Dương 1
Denver 1
Dublin 1
Frankfurt am Main 1
Gatchina 1
Guarulhos 1
Guayaquil 1
Guilin 1
Hamad Town 1
Helsinki 1
Hermitage 1
Horizonte 1
Isidro Casanova 1
Jakarta 1
Lanús 1
Las Vegas 1
Latacunga 1
Leme 1
London 1
Louisville 1
Marcelino Ramos 1
Miguel Pereira 1
Montreal 1
Moscow 1
Naples 1
New Iberia 1
Newark 1
Orem 1
Perugia 1
Petrolina 1
Phoenix 1
Piúma 1
Poplar 1
Portoviejo 1
Qarshi 1
Quilmes 1
Rio de Janeiro 1
Salvador 1
San Francisco 1
San Jose 1
Santo André 1
St Petersburg 1
Stockholm 1
Suzano 1
São Gonçalo 1
São Paulo 1
Tatuí 1
Toronto 1
Três Lagoas 1
Warsaw 1
Totale 165
Nome #
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 58
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV 50
Real-life monocentric Biktarvy cohort from Perugia 42
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort 40
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV 40
Totale 230
Categoria #
all - tutte 1.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20248 0 0 0 0 0 0 0 0 0 0 2 6
2024/202592 0 4 3 0 3 5 4 9 20 13 17 14
2025/2026130 13 23 16 41 27 10 0 0 0 0 0 0
Totale 230